MedPath

Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI

Not Applicable
Completed
Conditions
Nicotine Dependence
Registration Number
NCT01982617
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The investigators primary hypothesis was that recipients of the Motivational Interviewing intervention would be significantly more likely than those assigned to the Psychoeducation intervention to demonstrate increased readiness to quit smoking at the end of the intervention and to seek smoking cessation treatment in the one month period following the intervention. We also predicted that the Psychoeducation intervention would result in greater improvements in smoking knowledge.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • 18-65 years of age
  • Had a diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic major depressive disorder by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria
  • Smoked at least 10 cigarettes per day
  • At baseline, reported not being ready to quit smoking within the next 30 days (i.e., in precontemplation or contemplation stages).
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Readiness to quit (Stage of Change)30 days

efficacy of a cognitive behavioral therapy/motivational (MI) interviewing intervention relative to a psychoeducational (ED) intervention in terms of promoting increased readiness to quit smoking among smokers with severe mental illness who were not ready to quit.

Secondary Outcome Measures
NameTimeMethod
Smoking Knowledge30 days

Changes in smoking knowledge obtained through cognitive behavioral therapy/motivational (MI) interviewing intervention relative to a psychoeducational (ED) intervention

Trial Locations

Locations (1)

Schizophrenia Program of the Massachusetts General Hospital, Freedom Trail Clinic, 25 Staniford St

🇺🇸

Boston, Massachusetts, United States

Schizophrenia Program of the Massachusetts General Hospital, Freedom Trail Clinic, 25 Staniford St
🇺🇸Boston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.